KITT vs OCEA

Over the past 5 years, Nauticus Robotics, Inc.

(KITT) delivered a total return of -100. 0%, compared to -100. 0% for Ocean Biomedical, Inc. (OCEA). Over 10 years, the gap is even starker: KITT returned -100. 0% versus OCEA's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ocean Biomedical, Inc.

(OCEA) is the lower-risk stock at 0. 30β versus Nauticus Robotics, Inc. 's 3. 01β — meaning KITT is approximately 920% more volatile than OCEA relative to the S&P 500.

On earnings-per-share growth, the picture is similar: Nauticus Robotics, Inc.

grew EPS 96. 8% year-over-year, compared to -153. 2% for Ocean Biomedical, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Ocean Biomedical, Inc.

(OCEA) is the more profitable company, earning 0. 0% net margin versus -774. 0% for Nauticus Robotics, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OCEA leads at 0. 0% versus -449. 8% for KITT. At the gross margin level — before operating expenses — OCEA leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Ocean Biomedical, Inc.

(OCEA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 30)). Nauticus Robotics, Inc. (KITT) carries a higher beta of 3. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OCEA: -100. 0%, KITT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (KITT (Industrials) and OCEA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KITT is a small-cap high-growth stock; OCEA is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.